Surgery Partners, Inc.
SGRY
$21.48
-$0.36-1.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -168.10M | -60.60M | -33.80M | 600.00K | -11.90M |
| Total Depreciation and Amortization | 152.60M | 149.80M | 128.50M | 118.10M | 118.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 434.50M | 315.20M | 299.10M | 253.90M | 251.10M |
| Change in Net Operating Assets | -118.90M | -153.10M | -103.10M | -112.60M | -63.50M |
| Cash from Operations | 300.10M | 251.30M | 290.70M | 260.00M | 293.80M |
| Capital Expenditure | -90.40M | -87.90M | -86.60M | -85.50M | -88.80M |
| Sale of Property, Plant, and Equipment | 2.60M | 1.50M | 1.20M | 19.30M | 25.80M |
| Cash Acquisitions | -378.80M | -322.40M | -301.10M | -93.90M | -80.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -21.90M | -26.10M | -24.40M | -77.90M | -82.60M |
| Cash from Investing | -488.50M | -434.90M | -410.90M | -238.00M | -225.60M |
| Total Debt Issued | 1.73B | 2.17B | 2.10B | 1.00B | 826.60M |
| Total Debt Repaid | -1.28B | -1.81B | -1.75B | -911.40M | -807.10M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -188.40M | -192.80M | -189.80M | -174.10M | -174.70M |
| Cash from Financing | 262.00M | 169.40M | 156.30M | -82.30M | -155.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.60M | -14.20M | 36.10M | -60.30M | -87.00M |